Status:
RECRUITING
Biofilm Accumulation in Zirconia vs. Titanium Implants
Lead Sponsor:
Universidad Complutense de Madrid
Conditions:
Implant Infection
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The aim of this randomized clinical trial is to compare the amount and type of biofilm formed on the surface of zirconia implants compared to titanium implants. A pilot randomized clinical trial will...
Detailed Description
Study design: The present protocol is designed as a randomized controlled clinical trial. The set of procedures of the present clinical trial will be carried out in the Master of Oral Surgery and Imp...
Eligibility Criteria
Inclusion
- Patients of both sexes of legal age.
- Patients ASA I, II and III.
- Subsequent to the placement of a single implant.
- Patients who accept the surgery and sign the informed consent.
Exclusion
- Pregnant or breastfeeding women
- Patients who cannot attend follow-up appointments after surgery.
- Patients with implants adjacent to the area to be treated.
- Patients with uncontrolled periodontal pathology.
- Systemic pathology that contraindicates the surgical procedure: hepatitis or other infectious diseases, oncological treatment, untreated or uncontrolled systemic pathology: diabetes mellitus, arterial hypertension, osteoporosis, heart failure, valvular heart disease, history of endocarditis, acute myocardial infarction less than 6 months ago, stroke less than 6 months ago, history of venous thromboembolism, arrhythmias, vitamin D deficiency, Parkinson's and Alzheimer's disease, dementia, psychiatric disorders, liver disease, COPD, chronic renal failure, immunosuppressed, autoimmune diseases, inflammatory bowel disease, digestive pathology, phosphocalcium metabolism diseases, hyper- or hypothyroidism, endocrinopathies, celiac disease, collagenosis, etc.
- Pharmacological treatment with anticoagulants, antiaggregants, bisphosphonates, monoclonal antibodies, serotonin reuptake inhibitors, immunosuppressants, corticosteroids, antipsychotics.
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06075017
Start Date
December 1 2024
End Date
December 1 2026
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Complutense University of Madrid
Madrid, Spain, 28040